There are roughly about 4 million Thais and about 380,000 expats in Thailand afflicted with this disease. Keep updated with ways to control and manage diabetes while also monitor what’s developing in the research sector of this disease.
Medical Devices - GlucoScreen Apr 19, 2023 2 months ago
Medical Devices: The University of Washington's GlucoScreen is revolutionizing prediabetes diagnosis with its innovative smartphone-based system. Researchers from the university have developed a battery-free test strip capable of accurately measuring blood glucose levels, paving the way for more accessible and cost-effective at-home testing for prediabetes. With its compatibility with any smar...
Medical Devices - FreeStyle Libre Glucose Monitors Apr 08, 2023 2 months ago
Medical Devices: More than 4 million FreeStyle Libre glucose monitors have been urgently recalled by Abbott after the U.S. Food and Drug Administration (FDA) announced potential fire hazards associated with the devices. The lithium-ion batteries used in the system may get extremely hot, spark or catch fire if not properly stored, charged or exposed to liquids or foreign materials. This recall, cla...
Medical News: A new study by researchers from Sichuan University-China, Sun Yat-sen University-China and the Aviation Industry Corporation of China Hospital-China has shockingly found that diabetes can also contribute to the development of a variety of lung conditions including asthma, chronic obstructive pulmonary disease (COPD) and more so Idiopathic Pulmonary Fibrosis (IPF) due to its effects i...
AI-In-Medicine - Taiwan - Point-of-Care AI-DR - diabetic retinopathy - diabetic macular edema Mar 29, 2023 2 months ago
AI In Medicine: Taiwan’s Industrial Technology Research Institute (ITRI), a leading non-profit research organization has introduced a groundbreaking AI-assisted system called Point-of-Care AI-DR.
This innovative software is designed for rapid diagnosis of diabetic retinopathy (DR) and diabetic macular edema (DME) and can be integrated into handheld and desktop fundus cameras commonl...
Diabetes News - Anthocyanins Mar 26, 2023 2 months ago
Diabetes News: A new study by researchers from University of Turku-Finland has found that anthocyanins from purple fruits and vegetables helps in various issues associated with diabetes.
Synkeä Sakari -A Finnish purple potato variety abundant in acylated anthocyanins.
Pic Credit: TEIJA TUISKU
Anthocyanins, the pigments responsible for red-orange to blue-violet hues in frui...
Source: COVID-19 Drugs - Diabetics - SGLT-2 Inhibitors Dec 08, 2022 6 months ago
COVID-19 Drugs: A new study by researchers from Fujian Medical University -China, Fujian Provincial Hospital-China and Fujian Academy of Medical Sciences-China has found that diabetics taking SGLT-2i drugs like canagliflozin, dapagliflozin, and empagliflozin prior to contracting COVID-19 have reduced adverse outcomes.
SGLT2i or sodium-glucose cotransporter-2 inhibitors are a class of prescription...
COVID-19 News - New Onset Diabetes In Long COVID Dec 04, 2022 6 months ago
COVID-19 News: A prominent and distinguished Long COVID researcher, Dr Ziyad Al-Aly from the Clinical Epidemiology Center, VA Saint Louis Health Care System, Missouri-USA and also the Institute for Public Health, Washington University in Saint Louis, Missouri-USA has warned that otherwise previously health individuals, irrespective if they were vaccinated or unvaccinated with the various COVID-19 ...
Source: Medical News -COVID-19-Diabetes- Pediatrics Sep 24, 2022 9 months ago
A new study by researchers from Case Western Reserve University School of Medicine, Ohio-USA and The MetroHealth System-Ohio-USA has found that SARS-CoV-2 infections are associated with increase in new diagnoses of type 1 diabetes in youth, by as much as 72%!
Already the incidence of new-onset type 1 diabetes (T1D) increased during the COVID-19 pandemic, and this increase has been associated wi...
Source: Medical News -NSAIDs-Heart Failure Sep 07, 2022 9 months ago
A new study by Danish researchers the Copenhagen University Hospital in Denmark has found that the usages of common NSAIDs (non-steroidal anti-inflammatory drugs) like Ibuprofen and Diclofenac by diabetics were linked to a higher risk of heart failure.
The study findings were presented during the recent European Society of Cardiology annual congress or ESC Congress 2022 and will be publis...
Source: Medical News - Stevia, Saccharin And Sucralose Sep 06, 2022 9 months ago
A new study led by Dr Kathleen A. Page, a Professor at the Division of Endocrinology, Department of Internal Medicine, Keck School of Medicine of the University of Southern California,-Los Angeles, has found that using artificial sweeteners like stevia, saccharin and sucralose can also cause glycemic response impairment via the gut microbiome and also cause more long term health issues.
N...
Source: Medical Devices - Non-Invasive Continuous Glucose Monitor Sep 05, 2022 9 months ago
Medical Devices: GlucoRx Ltd, a medical technology company based in Surrey, United Kingdom that specializes in home use glucose monitoring devices for diabetics along with Cardiff University are on schedule to launch the world’s first truly non-invasive continuous glucose monitor in Europe by early 2023. The product will then be launched in the Asia-Pacific region by mid-2023 and subsequentl...
Source: Drug News - GLP-1 Receptor Agonists Drugs Sep 05, 2022 9 months ago
Drug News: Medical researchers from the U.S FDA have discovered that diabetics taking glucagon-like peptide-1 (GLP-1) receptor agonists drugs like exenatide, dulaglutide, semaglutide and lixisenatide have a higher risk of developing acute cholecystitis and even higher risk of death!
The study team conducted a detailed meta-analysis from data of the of U.S FDA's reporting system for ad...
Source: Medical News - SARS-CoV-2 - Pancreas May 05, 2022 1 year ago
Italian researchers from Universitá di Milano, have in a new study found that the SARS-CoV-2 coronavirus is able to directly and also indirectly affect the pancreatic islets of the host and cause pancreatic inflammation that can lead to Post COVID Hyperglycemia and other health conditions and issues!
It is interesting that ever since the Omicron wave, incidences of not only hypergl...
Source: Medical News - Diabetes & COVID-19 Mar 17, 2022 1 year ago
A new study conducted by researchers from the German Diabetes Center at the Leibniz Center for Diabetes Research-Heinrich Heine University-Germany and the Medical Faculty and University Hospital Düsseldorf-Heinrich Heine University-Germany has alarmingly shown that even mild SARS-CoV-2 infections are triggering new onset type 2 diabetes in many.
Graphical Abstract
The study team aimed...
SARS-CoV-2-GP73: A new study led by researchers from the Beijing Institute of Biotechnology involving more than 8 other research institutions and hospitals in China has found that SARS-CoV-2 infection induces the increase of the circulating protein GP73 that causes dysglycaemia, more specifically the GP73 proteins act as a kind of glucogenic hormone contributing to SARS-CoV-2-induced hypergl...
Source: COVID-19-Hypoglycemia Jan 05, 2022 1 year ago
COVID-19 Hypoglycemia: Researchers from Weill Cornell Medicine - New York City in a new study have found that the SARS-Cov-2 coronavirus is able to triggers adipose tissue dysfunction, driving insulin resistance and causing hyperglycemia in infected individuals. In the study involving more than 3,800 COVID-19 patients, almost 50% developed high blood sugar levels.
Should further studies a...
Source: Medical News-GRP78, Metformin And SARS-CoV-2 Nov 06, 2021 2 years ago
A new study by Japanese researchers from Osaka University shows that that older, obese patients with diabetes are more susceptible to severe COVID-19 infection because the SARS CoV-2 spike protein also binds to GRP78, which is highly expressed in fat tissue.
According to the study abstract, “Aging, obesity, and diabetes are major risk factors for the severe progression and outcome of SARS-C...
Source: COVID-19 And Hyperglycaemia Sep 03, 2021 2 years ago
Researchers from the Università di Milano in Italy and the from the Nephrology Division, Boston Children’s Hospital,Harvard Medical School-USA are warning that there will be a huge surge of diabetes caseloads in individuals who had been infected with the COVID-19 disease despite being healthy prior to the SARS-CoV-2 infection.
COVID-19 patients who were otherwise healthy...
COVID-19 News: Globally a new phenomenon is being witnessed in which those that never had a history of diabetes before but upon being infected with the new SARS-CoV-2 coronavirus are experiencing a sudden elevation of blood sugar levels and in some cases are ending up with full blown diabetes weeks after so called ‘COVID-19 recovery.’ https://www.thailandmedical.news/news/breaking-covi...
Source: Metformin-COVID-19 Dec 29, 2020 2 years ago
Metformin-COVID-19: The American Association of Clinical Endocrinologists in a recent published clinical case report warns that diabetes patients taking SGLT2 Inhibitors to manage their diabetes may develop rare and sometimes serious complications upon contracting COVID-19.
SGLT2 inhibitors are a class of prescription medicines that are FDA-approved for use with diet and exercise to ...
Source: COVID-19 And Metformin Sep 04, 2020 3 years ago
COVID-19 And Metformin: A new study comprising researchers from China, America and UK have shown that metformin as a diabetic drug for COVID-19 patients with type 2 diabetes was associated with higher incidence of acidosis which could lead to kidney complications but it was not associated with higher mortality rates.
The study findings were published in the journal: Cell Metabolism https:...
Diabetes News: Researchers from Salk Institute-California have made a major breakthrough in the pursuit of a safe and effective treatment for type 1 diabetes, an illness that impacts an estimated 1.7 million Americans with a cost of US$14.5 billion annually.
Utilizing stem cell technology, the research team generated the first human insulin-producing pancreatic cell clusters abl...
Source: Diabetes And Canagliflozin Aug 09, 2020 3 years ago
Diabetes And Canagliflozin: A serious drug interaction between canagliflozin (Invokana) and rosuvastatin (Crestor) was thought to cause liver and muscle toxicity (myotoxoicty) in a female patient in Canada, according to a new published case report.
The case report was published in the medical journal: Annals of Internal Medicine as reported by Dr David Juurlink, MD, PhD, of Sunnybrook Health Sc...
Source: Diabetes and COVID-19 Jul 02, 2020 3 years ago
Diabetes And COVID-19: A case study by German researchers from University of Kiel have confirmed that the Sars-CoV-2 coronavirus can trigger diabetes and insulin dependency in young adults who have otherwise been healthy with any prior history of sickness or diabetes. It is assumed that the diabetes is triggered by the SARS-CoV-2 coronavirus attacking the pancreas thru the ACE-2 receptors present ...
Diabetes: Researchers from Emory University School of Medicine, Georgia, United States in a new study have demonstrated that blood sugar control may not protect diabetes patients from vision loss as earlier believed. The research results, however, do not deny the importance of tight blood sugar control in diabetics avoiding eye complications.
Individuals with diabetes can have diabetic re...
Source: Vildagliptin Versus Metformin Jun 17, 2020 3 years ago
Vildagliptin an oral anti-hyperglycemic agent that goes by the trade name Galvus showed similar protective effects as metformin on the beta-cell function, reduced insulin resistance, and blood sugar levels in newly diagnosed Asian Indians with type 2 diabetes (T2D), according to a recent study.
The research trial further found that there was an improved insulin sensitivity in patients treated wi...
Diabetes: The elderly with type 1 diabetes (T1D) is a growing but under-studied population that is prone to hypoglycemia, particularly when diabetes is longstanding. Unknown to many, hypoglycemia can cause altered mental status and sometimes seizure or loss of consciousness, which can prove fatal.
According to this six-month, multi-site clinical study trial called the Wireless Innovation for Sen...
Source: Thailand Diabetes Jun 14, 2020 3 years ago
Diabetes: Indian Researchers led by a Keralite have found in a new study that green jackfruit powder decreases blood sugar and glycosylated hemoglobin (HbA1c) in diabetes patients.
The study findings have been published in the American Diabetes Association’s medical journal: Diabetes. https://diabetes.diabetesjournals.org/content/69/Supplement_1/719-P
The study suggests a thera...
Source: Diabetes and COVID-19 Jun 13, 2020 3 years ago
Diabetes and COVID-19: New emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in otherwise healthy people and also cause severe complications of pre-existing diabetes.
The report was published in the medical journal: New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJMc2018688
The report was initiated by an international group of 1...
Source: Diabetic Retinopathy Jun 12, 2020 3 years ago
Diabetic retinopathy is a typical complication of diabetes and a leading cause of blindness in the world. A new research by scientist from University Of Oklahoma show that visual function in diabetic mice was significantly improved after treatment with a single dose of visual chromophore 9-cis-retinal, a vitamin A analog that can form a visual pigment in the retina cells, thereby producing a light...
Source: Diabetes And COVID-19 Jun 03, 2020 3 years ago
Diabetes And COVID-19: French researchers in a new study show that body mass index (BMI) is associated with tracheal intubation and/or death within seven days among individuals with diabetes hospitalized for COVID-19.
Dr Bertrand Cariou from the University of Nantes in France, and his research team conducted a multicenter study in 1,317 people with diabetes (88.5 percent with type 2 diabe...
Source: Metformin and Diabetes May 30, 2020 3 years ago
Metformin: The US FDA has issued warnings that many brands and versions of the drug Metformin that is used by diabetics in the US and around the world have been found to be contaminated with a carcinogenic compound called N-Nitrosodimethylamine.
The U.S. health regulators have started telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory te...
Diabetes: The world’s first study of COVID-19 to specifically analyze the effect of the diabetes in hospitalized patients has found that one in ten patients dies within 7 days of hospital admission, and one in five is intubated and mechanically ventilated by this point.
The study is published in Diabetologia (the journal of the European Association for the Study of Diabete...
Diabetes: According to medical researchers from the University of Buffalo, a century old drug used to treat sleeping sickness, could be been repurposed to fight oral mucositis and diabetic foot ulcers. http://inventions.arizona.edu/technologies/ua18-037_advanced-engineered-formulations-of-suramin-microparticles-and-nanoparticles-for-drug-delivery-and-applications-therein
The rec...
Source: Thailand Diabetes News May 22, 2020 3 years ago
Diabetes: Canadian medical researchers have isolated metabolites in the blood that can accurately predict whether a female will develop type 2 diabetes after experiencing a transient form of illness during pregnancy.
This breakthrough could lead to a diagnostic test that would aid physicians identify females at greatest risk and help them potentially avert the disease through intervention...
Source: Diabetes And COVID-19 May 17, 2020 3 years ago
Diabetes and COVID-19: A new research shows that people with type 2 diabetes (T2D) are at greater risk of a poor outcome should they become infected with the SARS-CoV-2 coronavirus that causes COVID-19. However there is some positive news: people with T2D whose blood sugar is well controlled fare much better than those with more poorly controlled blood sugar.https://www.sciencedirect.com/science/a...
Source : Thailand Medical News Feb 04, 2020 3 years ago
According to a new study by a University of Alberta researchers, pregnant women diagnosed with diabetes who have elevated fasting (pre-meal) blood sugar levels are more likely to face complications than those who have only elevated post-meal glucose levels.
Cardiology Professor Dr Padma Kaul, who is also an adjunct professor in the School of Public Health told Thailand Medical News, "...
Source: Thailand Medical News Jan 10, 2020 3 years ago
A breakthrough discovery that could improve the clinical delivery of insulin for people living with diabetes, medical scientists from Australia have developed a non-fibrillating form of human insulin.
Utilizing a novel glycosylation technique, an international research team led by Associate Professor Dr Akhter Hossain from the Florey Institute of Neuroscience and Mental Health, has successfully...
Source: Thailand Medical News Dec 24, 2019 4 years ago
Medical researchers at Karolinska Institutet in Sweden have deciphered the diabetogenic role of a certain type of calcium channel in insulin-secreting beta cells. The researchers believe that blockade of these channels could be a potential new treatment strategy for diabetes.
The recent study is published in the scientific journal PNAS.
The CaV3.1 channels have a marginal role in healthy ...
Source: Thailand Medical News Nov 22, 2019 4 years ago
A new broad European study involving multiple medical institutes finds that patients with diabetes do not benefit from implantable cardioverter defibrillator (ICD) pacemakers.
Typically, current treatment recommendations support ICD pacemaker treatment for all patients with severe malfunction of the left ventricle. The purpose of the defibrillator is to protect the patient from life-threatening...
Source: Thailand Medical News Nov 05, 2019 4 years ago
Pharma giant Sanofi has announced that its Toujeo (insulin glargine 300units/mL) is effective at reducing average blood sugar (HbA1c) in children and adolescents with type 1 diabetes, compared to insulin glargine 100units/mL (Gla-100).
In the Phase III EDITION-JUNIOR study of 463 children and adolescents over the age of six, Toujeo met its primary endpoint of non-inferior reduction of HbA1c compa...
Source: Thailand Medical News Sep 24, 2019 4 years ago
Thailand Diabetes
Researchers from Charles University in Prague have found that real-time continuous glucose monitoring (rtCGM) is effective among those with type 1 Diabetes irrespective of what modalities are used to deliver insulin to the body.
The three year trial called COMISAIR (Comparison of Different Treatment Modalities for Type 1 Diabetes Including Sensor-Augmented Insulin Regim...
Source: Thailand Medical News Jul 21, 2019 4 years ago
Endowed Professor of Cardiovascular Medicine from the University Of California-Davis, Dr Nipavan Chiamvimonvat who has a long litany of professional and international awards and more than 135 medical research papers published, has once again with her team made another major discovery as to the actual mechanism as to how diabetes causes vascular disease.
Prof Dr Nipavan Chiamvomonvat
Toget...
Source: Thailand Medical News Jun 10, 2019 4 years ago
Findings from the Rewind (Researching Cardiovascular Events with a Weekly Incretin in Diabetes) Trial by McMaster University and Hamilton Health Sciences , has indicated that the drug dulaglutide (brandname: Trulicity) reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.
The trial which was one of the largest of its kind involved more than 9,90...
Source: Thailand Medical News Jun 06, 2019 4 years ago
A new discovery by a research team from Heidelberg University in Germany reveals that lowering serum cholesterol levels in patients with type 2 diabetes is associated with diabetic polyneuropathy (DPN).
Diabetic neuropathy is a type of nerve damage that occurs when an individual has diabetes. High blood sugar (glucose) can injure nerves throughout the body. Diabetic neuropathy most often ...
Source: Thailand Medical News Jun 02, 2019 4 years ago
Diabetic retinopathy is the leading cause of blindness in adults across the world, but the most challenging aspect of the disease is that it often goes undetected until too much damage has been done and the person affected is already losing their vision. Most diabetics have few treatment options as the severity of the condition and vision loss worsens.
Regeneron Pharmaceuticals D...
Source: Thailand Medical News May 18, 2019 4 years ago
Diabetes affects about 442 million people worldwide (2019) and the figures keep rising with Thailand alone having more than 4.7 million people with diabetes.
Diabetes is the result when a person’s body is not able to produce enough insulin naturally (type 1 diabetes) or when the insulin produced is not efficiently used in the body (type 2 diabetes). Insulin is produced i...
Source: Harvard Medical School, Boston May 10, 2019 4 years ago
Statin use may lower the risk for primary open-angle glaucoma (POAG), according to a study published online May 2 in JAMA Ophthalmology.
High cholesterol is associated with an increased risk of developing glaucoma, but a new study suggests taking statins to lower cholesterol helps to reduce this risk.
Glaucoma is a group of eye conditions that can damage the optic nerve, typic...
If you have type 2 diabetes and are taking a newer class of medications to treat your disease—but one day you notice pain, redness and a foul odor in your genital area.If this happens, new research suggests you need to see your doctor immediately, because you may be suffering from Fournier gangrene. Also known as a "flesh-eating" disease, this infection attacks your genital or anal...
Source: National Institutes of Health,US May 02, 2019 4 years ago
Taking a folic acid supplement daily before pregnancy may reduce the risk of gestational, or pregnancy-related, diabetes, according to a study by researchers at the National Institutes of Health and other institutions.
Folic acid is the synthetic form of folate, or vitamin B9, which is found in leafy green vegetables, nuts, peas, beans and other foods. The U.S. Preventive Services T...
Source: University of Texas Health Science Center at San Antonio May 01, 2019 4 years ago
Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. Study coauthor Jane Lynch, M.D., FAAP, professor of pediatrics at UT Health San Antonio, said the drug, liraglutide, in combination with an existing medication, metformin, showed robust effect in treating chi...
Source: Uppsala University Apr 27, 2019 4 years ago
Many diabetes patients do not only have problems with their insulin, but also with the release of the hormone glucagon. Researchers at Uppsala University have now discovered a regulation mechanism which could provide an opportunity to improve blood glucose control in these patients.
The hormone glucagon, which is released from alpha cells in the pancreas, plays a vital role in blood glucos...
Source: University of Pennsylvania Apr 22, 2019 4 years ago
Whether a wound -- such as a diabetic foot ulcer -- heals or progresses to a worse outcome, including infection or even amputation, may depend on the microbiome within that wound. A new study from the Perelman School of Medicine at the University of Pennsylvania found specific strains of the common pathogen Staphylococcus aureus (S. aureus) are associated with wounds that do not heal. Researc...
Source: University of Edinburgh Apr 13, 2019 4 years ago
Researchers say patients should continue to take the drugs, which are commonly prescribed to older men, but warn they may need additional health checks.
The team stressed that current treatment guidelines do not need to change, based on their study of patient health records.
Men with enlarged prostates are commonly prescribed drugs called 5-alpha-reductase inhibitors that reduce the production ...
Source: Proceedings From ENDO 2019, Endocrine Society Annula Meeting in new Orleans, LA. Mar 24, 2019 4 years ago
Using the hemoglobin A1c blood test to diagnose diabetes tends to underestimate the prevalence of the disease, according to a new study presented on Saturday, March 23 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.
"Based on our findings, A1c should not be solely used to determine the prevalence of diabetes," said lead researcher Maria Me...
.jpg)
.jpg)
.jpg)
.jpg)
